Praxis Precision Medicines (PRAX) Accounts Payables: 2022-2025
Historic Accounts Payables for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $30.8 million.
- Praxis Precision Medicines' Accounts Payables rose 105.32% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.8 million, marking a year-over-year increase of 105.32%. This contributed to the annual value of $12.5 million for FY2024, which is 115.44% up from last year.
- Praxis Precision Medicines' Accounts Payables amounted to $30.8 million in Q3 2025, which was up 6.89% from $28.8 million recorded in Q2 2025.
- Over the past 5 years, Praxis Precision Medicines' Accounts Payables peaked at $30.8 million during Q3 2025, and registered a low of $5.8 million during Q4 2023.
- In the last 3 years, Praxis Precision Medicines' Accounts Payables had a median value of $12.5 million in 2024 and averaged $15.1 million.
- As far as peak fluctuations go, Praxis Precision Medicines' Accounts Payables plummeted by 60.37% in 2023, and later soared by 251.82% in 2025.
- Quarterly analysis of 4 years shows Praxis Precision Medicines' Accounts Payables stood at $14.7 million in 2022, then crashed by 60.37% to $5.8 million in 2023, then spiked by 115.44% to $12.5 million in 2024, then spiked by 105.32% to $30.8 million in 2025.
- Its last three reported values are $30.8 million in Q3 2025, $28.8 million for Q2 2025, and $22.9 million during Q1 2025.